FC
Finepoint Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-435,785
| Closed | -$17M | – | 16 |
|
|
2025
Q1 | $17M | Sell |
435,785
-12,150
| -3% | -$475K | 1.3% | 7 |
|
|
2024
Q4 | $24.3M | Buy |
447,935
+59,100
| +15% | +$3.2M | 1.48% | 8 |
|
|
2024
Q3 | $19.6M | Hold |
388,835
| – | – | 1.42% | 8 |
|
|
2024
Q2 | $17.1M | Buy |
388,835
+27,919
| +8% | +$1.23M | 4.85% | 7 |
|
|
2024
Q1 | $18.1M | Sell |
360,916
-534,084
| -60% | -$26.8M | 4.65% | 8 |
|
|
2023
Q4 | $62.7K | Buy |
895,000
+563,584
| +170% | +$39.5K | 0.02% | 19 |
|
|
2023
Q3 | $18.9M | Buy |
331,416
+29,416
| +10% | +$1.68M | 9.41% | 1 |
|
|
2023
Q2 | $15.4M | Buy |
+302,000
| New | +$15.4M | 5.33% | 10 |
|
|
2021
Q4 | – | Sell |
-382,400
| Closed | -$3.77M | – | 73 |
|
|
2021
Q3 | $3.77M | Buy |
382,400
+32,400
| +9% | +$320K | 0.64% | 42 |
|
|
2021
Q2 | $3.62M | Buy |
+350,000
| New | +$3.62M | 0.68% | 39 |
|